NCT07891533Phase 2Not yet recruiting

Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera

Study sponsor: AN2 Therapeutics, Inc · ANTX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-04Estimated
Enrollment · participants75Estimated
Source updated2026-10-23Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.